Sign in
CompletedPhase 3

Methylene Blue for the Treatment of Septic Shock

Key facts

Who runs it
Northern Jiangsu People's Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
88 people enrolled
Started
5 Aug 2024
Ended
24 Oct 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Methylene Blue
  • Placebo
Record updated
4 February 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • age 18 years old or older
  • diagnosis of septic shock within 12 h

Who cannot take part

  • recent intake (4-weeks) of selective serotonin re-uptake inhibitors
  • definitive pulmonary hypertension or chronic pulmonary heart disease
  • known allergy to methylene blue, phenothiazines, or food dyes
  • anticipated death from a preexisting disease within 90 days after randomization (as determined by the enrolling physician)
  • known glucose-6 phosphate dehydrogenase (G-6PD) deficiency
  • pregnant
  • refusal of the attending staff or patient family
  • participated in other study

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the efficacy and safety of methylene blue among adult patients with septic shock.

The 2 groups in the trial

  • Methylene BlueTreatment being tested

    Methylene Blue 100mg will be diluted in 40ml 5% dextrose solution. Methylene Blue(1 mg/kg/IBW iv over 30min+0.25mg/kg/h x 6h) x 5-days/ discontinution of norepinephrine /ICU discharge (whichever occurred first).

  • PlaceboPlacebo, for comparison

    5% dextrose solution in a volume to match experimental arm component.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Initiation of Methylene Blue for Septic Shock in Adults: A Randomized Clinical Trial
Record updated
4 February 2026